-
-
-
-
-
-
-
Avalo Reports First Quarter 2025 Financial Results and Recent Business Updates
-
-
-
-
-
-
-
Oppenheimer Upgrades Avalo Therapeutics (AVTX) to Outperform following AVTX-009 acquisition
-
-
-
-
-
-
-
Avalo Therapeutics Successfully Eliminates $35 Million Debt Paving the Way for Future Growth and Innovation
-
-
-
-
-
-
-
Avalo Appoints Two New Independent Directors to Its Board
-
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

